Demeclocycline 150mg capsules

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Demeclocycline hydrochloride

Available from:

Advanz Pharma

ATC code:

J01AA01

INN (International Name):

Demeclocycline hydrochloride

Dosage:

150mg

Pharmaceutical form:

Oral capsule

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 05010300; GTIN: 5021691108436

Patient Information leaflet

PATIENT INFORMATION
DEMECLOCYCLINE HYDROCHLORIDE 150MG CAPSULES
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist or
nurse.
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist or
nurse. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Demeclocycline Hydrochloride Capsules are and what they are
used for
2. What you need to know before you take Demeclocycline Hydrochloride
Capsules
3. How to take Demeclocycline Hydrochloride Capsules
4. Possible side effects
5. How to store Demeclocycline Hydrochloride Capsules
6. Contents of the pack and other information
1. WHAT ARE DEMECLOCYCLINE HYDROCHLORIDE CAPSULES AND WHAT ARE THEY
USED FOR
Demeclocycline Hydrochloride Capsules contain the active substance
Demeclocycline Hydrochloride. This
is an antibiotic (kills bacteria) belonging to the tetracycline group
of antibiotics. It is used to treat a wide
range of infections caused by bacteria.
Some of these infections are:
•
Severe acne
• Infections of the brain and liver caused by the bacteria
Leptospira
• Infection caused by Brucella bacteria (brucellosis)
• Infections caused by Rickettsiae micro-organisms transmitted by
lice, fleas, ticks and mites
• Infections of the sex organs and organs associated with urination
(genito-urinary infections) such as an
infection called chancroid, non-gonococcal urethritis
• Rare infections such as Tularaemia and bubonic plague. It may also
be used to treat a rare condition in
which a tumour of the pituitary gland in your brain causes the amount
of sodium in your blood to be too
low.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DEMECLOCYCLINE
HYDROCHLORIDE CAPSULES
DO NOT TAKE DEMECLOCYCLINE HYDROCHLORIDE CAPSULES IF:
•
Y

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ledermycin Capsules 150mg
Demeclocycline Hydrochloride 150mg Capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
LEDERMYCIN capsules each contain 150mg of demeclocycline
hydrochloride.
3.
PHARMACEUTICAL FORM
capsule, hard
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
For the treatment of infections caused by tetracycline-sensitive
organisms. For
example, LEDERMYCIN is highly effective in the treatment of infections
caused by _Borrelia recurrentis _(relapsing fever),
_Calymmatobacterium _
_granulinatis _(granuloma inguinale), _Chlamydia _species
(psittacosis,
lymphogranuloma vereneum, trachoma, inclusion conjunctivitis),
_Francisella _
_tularensis _(tularaemia), _Haemophilus ducreyi _(chancroid),
_Leptospira _
(meningitis, jaundice), _Mycoplasma pneumoniae _(non-gonococcal
urethritis),
_Pseumomonas mallei _and _pseudomallei _(glanders and melioidosis),
_Rickettsiae _
(typhus fever, Q fever, rocky mountain spotted fever), _Vibrio
_species
(cholera). It is also highly effective, alone or in combination with
streptomycin, in the treatment of infections due to _Brucella _species
(brucellosis) and _Yersinia pestis _(bubonic plague). Severe acne
vulgaris.
Other sensitive organisms include: _Actinomyces israelii, Bacillus
anthracis _
(pneumonia), _Clostridium _species (gas gangrene, tetanus), _Entamoeba
_
_histolytica _(dysentery), _Neisseria gonorrhoeae _and anaerobic
species,
_Treponema pallidum _and _pertenue _(syphilis and yaws).
For the treatment of chronic hyponatraemia associated with the
syndrome of
inappropriate secretion of antidiuretic hormone (SIADH) secondary to
malignant disease, where water restriction is ineffective and the
patient does
not have concomitant cirrhosis.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_FOR ANTIBIOTIC USE _
_Adults _
_(Capsules_) - 600mg daily in 2 or 4 divided doses. For primary
atypical
pneumonia, the average daily dose is 900mg in 3 divided doses for 6
days.
_Elderly_
Use with caution in elderly